02:23 GMT20 April 2021
Listen Live
    UK
    Get short URL
    357
    Subscribe

    MOSCOW (Sputnik) – The United Kingdom has registered 30 cases of blood clots following vaccination with the AstraZeneca drug, the Medicines and Healthcare Products Regulatory Agency said.

    In mid-March, the United Kingdom reported only five thrombosis cases after the use of the AstraZeneca vaccine.

    "Up to and including 24 March, we have received 22 reports of cerebral venous sinus thrombosis (CVST) and 8 reports of other thrombosis events with low platelets, out of a total of 18.1 million doses of COVID-19 Vaccine AstraZeneca given by that date. There were no reports for the Pfizer/BioNTech vaccine", the agency said in a statement late Thursday.

    Several EU countries halted the rollout of AstraZeneca's COVID-19 vaccine in mid-March following dozens of reports of blood clotting after vaccination. However, the regulatory bodies found no direct link between the vaccination and thrombosis, and also said the benefits of the drug outweighed the existing risks. After that, several heads of EU countries and UK Prime Minister Boris Johnson were vaccinated with the AstraZeneca drug to restore public trust in the vaccine.

    Related:

    AstraZeneca May Have Included 'Outdated' Information in Trials, US Health Agency Says
    Third of Danes Don't Want to Get Vaccinated Against COVID-19 Amid AstraZeneca's Blood Clot Drama
    Denmark Extends Suspension of AstraZeneca for 3 Weeks
    Von Der Leyen Threatens to Block AstraZeneca Exports to UK Until Firm Makes Good on Deliveries to EU
    Germany's Vaccine Regulator Reports 31 Cases of Blood Disorder After AstraZeneca Jab
    Tags:
    coronavirus, COVID-19, vaccines, vaccine, AstraZeneca, UK
    Community standardsDiscussion